Last quarter (Q2 2022), Affluent Medical SA's total revenue was $―, a decrease of ― from previous quarter. In Q2, Affluent Medical SA's net income was $―. See Affluent Medical SA’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 21	Dec 20	Dec 17	Dec 16
Total Revenue	$ ―	$ 0.00	$ 0.00	$ 43.00K	$ 3.00K
Cost of Revenue	$ ―	$ 2.52M	$ 3.11M	$ ―	$ ―
Gross Profit	$ ―	$ -2.52M	$ -3.11M	$ ―	$ ―
Operating Expense	$ ―	$ 10.73M	$ 9.49M	$ 10.40M	$ 7.09M
Operating Income	$ ―	$ -13.25M	$ -12.59M	$ -10.36M	$ -7.09M
Net Non Operating Interest Income Expense	$ ―	$ -3.05M	$ -2.13M	$ -166.00K	$ -33.00K
Other Income Expense	$ ―	$ ―	$ ―	$ ―	$ ―
Pretax Income	$ ―	$ -15.26M	$ -14.53M	$ -10.42M	$ -7.22M
Tax Provision	$ ―	$ -437.00K	$ -209.00K	$ -1.67M	$ -1.39M
Earnings From Equity Interest Net Of Tax	$ ―	$ ―	$ ―	$ ―	$ ―
Net Income Common Stockholders	$ ―	$ -14.82M	$ -14.32M	$ -8.75M	$ -5.84M
Basic EPS	$ ―	$ ―	$ ―	$ ―	$ ―
Diluted EPS	$ ―	$ ―	$ ―	$ ―	$ ―
Basic Average Shares	$ ―	$ ―	$ ―	$ ―	$ ―
Diluted Average Shares	$ ―	$ ―	$ ―	$ ―	$ ―
Dividend Per Share	$ ―	$ ―	$ ―	$ ―	$ ―
Total Operating Income As Reported	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Basic E P S	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Diluted E P S	$ ―	$ ―	$ ―	$ ―	$ ―
Rent Expense Supplemental	$ ―	$ 64.00K	$ 58.00K	$ ―	$ ―
Total Expenses	$ ―	$ 13.25M	$ 12.59M	$ 10.40M	$ 7.09M
Net Income From Continuing And Discontinued Operation	$ ―	$ -14.82M	$ -14.32M	$ -8.75M	$ -5.84M
Normalized Income	$ ―	$ -15.85M	$ -14.91M	$ -8.83M	$ -5.76M
Interest Expense	$ ―	$ 3.06M	$ 2.17M	$ 166.00K	$ 36.00K
EBIT	$ ―	$ -12.20M	$ -12.36M	$ -10.26M	$ -7.19M
EBITDA	$ ―	$ -9.78M	$ -9.90M	$ -9.90M	$ -6.94M

Currency in USD

Affluent Medical SA Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing